Unrelated allogeneic bone marrow transplant in adrenoleukodystrophy using CD34+ stem cell selection

被引：4

作者：

Borker, A ^{[1
]}

Yu, LC ^{[1
]}

机构：

[1] Louisiana State Univ, Hlth Sci Ctr, Childrens Hosp New Orleans, Dept Pediat Hematol Oncol, New Orleans, LA 70118 USA

来源：

METABOLIC BRAIN DISEASE | 2002年 / 17卷 / 03期

关键词：

adrenoleukodystrophy; allogeneic BMT; CD34(+) selection;

D O I：

10.1023/A:1019969820308

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Adrenoleukodystrophy is an inherited disease characterized by progressive neurodegeneration with rapid deterioration to a vegetative state. Of the treatment modalities tried to date, BMT is the only one with the potential for cure. However, the high rate of morbidity and mortality associated with allogeneic transplant makes it necessary to try out novel measures to improve the outcome in these patients. We report here a case where we used CD34(+) stem cell selection for allogeneic unrelated-donor BMT in a patient with adrenoleukodystrophy.

引用

页码：139 / 142

页数：4

共 50 条

[1] Unrelated Allogeneic Bone Marrow Transplant in Adrenoleukodystrophy Using CD34+ Stem Cell Selection
Anupama Borker
Lolie C. Yu
[J]. Metabolic Brain Disease, 2002, 17 : 139 - 142
[2] Allogeneic Stem Cell Transplantation with CD34+ Cell Selection
Elisa Roldan
Miguel Angel Perales
Pere Barba
[J]. Clinical Hematology International, 2019, 1 (3) : 154 - 160
[3] Correlation of CD34+ cell counts with volume of bone marrow collected for allogeneic bone marrow harvests
Shaughnessy, PJ
Kissack, B
Bickford, DJ
Ririe, DW
Ornstein, DL
Lopez, J
Hensley, RE
Smith, R
Schroeder, MT
[J]. JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (06): : 891 - 894
[4] ENRICHMENT OF CD34+ STEM-CELLS FOR BONE-MARROW TRANSPLANTATION (POSITIVE STEM-CELL SELECTION)
BERENSON, R
HALLAGAN, J
HEIMFELD, S
BEARMAN, S
JONES, R
SHPALL, E
[J]. TRANSFUSION, 1992, 32 (08) : S1 - S1
[5] Controlling T cell dose in CD34+ allogeneic transplant
Loudovaris, M
Unverzagt, K
Yacob, D
Jaramillo, J
Bender, J
Deans, R
[J]. BONE MARROW TRANSPLANTATION, 1998, 21 : S100 - S100
[6] Poor bone marrow function can be durably improved by CD34+ selected stem cell boosts after allogeneic stem cell transplantation
Haen, S. P.
Faul, C.
Schumm, M.
Kanz, L.
Bethge, W. A.
Vogel, W.
[J]. ONKOLOGIE, 2012, 35 : 200 - 200
[7] T cell depletion utilizing CD34+ stem cell selection and CD3+ addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients
Geyer, Mark B.
Ricci, Angela M.
Jacobson, Judith S.
Majzner, Robbie
Duffy, Deirdre
Van de Ven, Carmella
Ayello, Janet
Bhatia, Monica
Garvin, James H., Jr.
George, Diane
Satwani, Prakash
Harrison, Lauren
Morris, Erin
Semidei-Pomales, Mildred
Schwartz, Joseph
Alobeid, Bachir
Baxter-Lowe, Lee Ann
Cairo, Mitchell S.
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (02) : 205 - 219
[8] Effective T-cell depletion of allogeneic blood and marrow grafts, using a CD34+ cell selection device.
Viret, F
Chabannon, C
Vey, N
Stoppa, AM
Faucher, C
Novakovitch, G
Oziel-Taieb, S
Gastaut, JA
Maraninchi, D
Blaise, D
[J]. BONE MARROW TRANSPLANTATION, 1998, 21 : S102 - S102
[9] Transplant CD34+ cell dose affects outcomes following allogeneic peripheral blood stem cell transplantation from a matched unrelated donor.
Nakamura, R
Palmer, J
Rodriguez, R
Parker, P
Senitzer, D
Stein, A
Rosenthal, J
Wang, S
Schriber, J
Forman, SJ
Nademanee, A
[J]. BLOOD, 2005, 106 (11) : 581A - 582A
[10] Allogeneic bone marrow stem cell transplantation following CD34+ immunomagnetic enrichment in patients with inherited metabolic storage diseases
G Gaipa
M Dassi
P Perseghin
N Venturi
P Corti
S Bonanomi
A Balduzzi
D Longoni
C Uderzo
A Biondi
G Masera
R Parini
B Bertagnolio
G Uziel
C Peters
A Rovelli
[J]. Bone Marrow Transplantation, 2003, 31 : 857 - 860

← 1 2 3 4 5 →